drugset / Trial / NCT03113448

0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy

NCT03113448

Phase 3 Completed 42 enrolled Thammasat University
RandomizedCrossoverQuadruple-blindTreatment

Summary

To study that 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial

Timeline

Start
2017-01-19
Primary completion
2017-04-21
Completion
2018-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capsaicin Small molecule 0.075 % Topical